Cell‐Dependent Pathogenic Roles of Filamin B in Different Skeletal Malformations
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 8956636
Abstract
Mutations of filamin B (FLNB) gene can lead to a spectrum of autosomal skeletal malformations including spondylocarpotarsal syndrome (SCT), Larsen syndrome (LRS), type I atelosteogenesis (AO1), type III atelosteogenesis (AO3), and boomerang dysplasia (BD). Among them, LRS is milder while BD causes a more severe phenotype. However, the molecular mechanism underlying the differences in clinical phenotypes of different FLNB variants has not been fully determined. Here, we presented two patients suffering from autosomal dominant LRS and autosomal recessive vitamin D‐dependent rickets type IA (VDDR‐IA). Whole‐exome sequencing revealed two novel missense variants in FLNB, c.4846A>G (p.T1616A) and c.7022T>G (p.I2341R), which are located in repeat 15 and 22 of filamin B, respectively. The expression of FLNBI2341R in the muscle tissue from our LRS patient was remarkably increased. And in vitro studies showed that both variants led to a lack of filopodia and accumulation of the mutants in the perinuclear region in HEK293 cells. We also found that c.4846A>G (p.T1616A) and c.7022T>G (p.I2341R) regulated endochondral osteogenesis in different ways. c.4846A>G (p.T1616A) activated AKT pathways through inhibiting SHIP2, suppressed the Smad3 pathway, and impaired the expression of Runx2 in both Saos‐2 and ATDC5 cells. c.7022T>G (p.I2341R) activated both AKT and Smad3 pathways and increased the expression of Runx2 in Saos‐2 cells, while in ATDC5 cells it activated AKT pathways through inhibiting SHIP2, suppressed the Smad3 pathway, and reduced the expression of Runx2. Our study demonstrated the pathogenic mechanisms of two novel FLNB variants in two different clinical settings and proved that FLNB variants could not only directly cause skeletal malformations but also worsen skeletal symptoms in the setting of other skeletal diseases. Besides, FLNB variants differentially affect skeletal development which contributes to clinical heterogeneity of FLNB‐related disorders.Keywords
Funding Information
- National Natural Science Foundation of China (81974124)
This publication has 34 references indexed in Scilit:
- Opsismodysplasia: implications of mutations in the developmental gene INPPL1Clinical Genetics, 2013
- Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesionsMolecular Biology of the Cell, 2011
- Common Sequence Variation in FLNB Regulates Bone Structure in Women in the General Population and FLNB mRNA Expression in Osteoblasts In VitroJournal of Bone and Mineral Research, 2009
- Disease-associated Substitutions in the Filamin B Actin Binding Domain Confer Enhanced Actin Binding Affinity in the Absence of Major Structural Disturbance: Insights from the Crystal Structures of Filamin B Actin Binding DomainsJournal of Molecular Biology, 2009
- Akt1 in Osteoblasts and Osteoclasts Controls Bone RemodelingPLOS ONE, 2007
- Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent mannerJournal of Cell Biology, 2007
- Filamin B mutations cause chondrocyte defects in skeletal developmentHuman Molecular Genetics, 2007
- Filamin B deficiency in mice results in skeletal malformations and impaired microvascular developmentProceedings of the National Academy of Sciences, 2007
- Filamins: promiscuous organizers of the cytoskeletonTrends in Biochemical Sciences, 2006
- Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring.Journal of Cell Biology, 1990